Efficacy and safety of pemafibrate administration in patients with dyslipidemia: a systematic review and meta-analysis

BACKGROUND: Using a meta-analysis of randomized controlled trials (RCTs), this study aimed to investigate the efficacy and safety of pemafibrate, a novel selective peroxisome proliferator-activated receptor α modulator, in patients with dyslipidemia. METHODS: A search was performed using the MEDLINE...

Descripción completa

Detalles Bibliográficos
Autores principales: Ida, Satoshi, Kaneko, Ryutaro, Murata, Kazuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429757/
https://www.ncbi.nlm.nih.gov/pubmed/30898163
http://dx.doi.org/10.1186/s12933-019-0845-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429757/
https://www.ncbi.nlm.nih.gov/pubmed/30898163
http://dx.doi.org/10.1186/s12933-019-0845-x

Ejemplares similares